Selected Publications
Mao X, Krenn K, Tripp T, Tretter V, Reindl-Schwaighofer R, Kraft F, Podesser BK, Zhu Y, Poglitsch M, Domenig O, Abraham D, Ullrich R. Tidal Volume-Dependent Activation of the Renin-Angiotensin System in Experimental Ventilator-Induced Lung Injury. Crit Care Med. 2022 Feb 22. doi: 10.1097/CCM.0000000000005495. Online ahead of print. PMID: 35191411
Bódi B, Pilz PM, Mártha L, Lang M, Hamza O, Fagyas M, Szabó PL, Abraham D, Tóth A, Podesser BK, Kiss A, Papp Z. Alterations in ACE and ACE2 Activities and Cardiomyocyte Signaling Underlie Improved Myocardial Function in a Rat Model of Repeated Remote Ischemic Conditioning. Int J Mol Sci. 2021 Oct 14;22(20):11064. doi: 10.3390/ijms222011064. PMID: 34681724
Zins K, Abraham D. Cancer Immunotherapy: Targeting Tumor-Associated Macrophages by Gene Silencing. Methods Mol Biol. 2020;2115:289-325. doi: 10.1007/978-1-0716-0290-4_17. PMID: 32006408
Boehme S, Hartmann EK, Tripp T, Thal SC, David M, Abraham D, Baumgardner JE, Markstaller K, Klein KU. PO2 oscillations induce lung injury and inflammation. Crit Care. 2019 Mar 27;23(1):102. doi: 10.1186/s13054-019-2401-1. PMID: 30917851
Pilz PM, Hamza O, Gidlöf O, Gonçalves IF, Tretter EV, Trojanek S, Abraham D, Heber S, Haller PM, Podesser BK, Kiss A. Remote ischemic perconditioning attenuates adverse cardiac remodeling and preserves left ventricular function in a rat model of reperfused myocardial infarction. Int J Cardiol. 2019 Jun 15;285:72-79. doi: 10.1016/j.ijcard.2019.03.003. Epub 2019 Mar 6. PMID: 30904281
Zins K, Heller G, Mayerhofer M, Schreiber M, Abraham D. Differential prognostic impact of interleukin-34 mRNA expression and infiltrating immune cell composition in intrinsic breast cancer subtypes. Oncotarget. 2018 May 1;9(33):23126-23148. doi: 10.18632/oncotarget.25226. eCollection 2018 May 1. PMID: 29796177
Zins K, Kovatchki D, Lucas T, Abraham D. PlGF and VEGF-A Regulate Growth of High-Risk MYCN-Single Copy Neuroblastoma Xenografts via Different Mechanisms. Int J Mol Sci. 2016 Sep 23;17(10):1613. doi: 10.3390/ijms17101613. PMID: 27669225
Zins K, Gunawardhana S, Lucas T, Abraham D, Aharinejad S. Targeting Cdc42 with the small molecule drug AZA197 suppresses primary colon cancer growth and prolongs survival in a preclinical mouse xenograft model by downregulation of PAK1 activity. J Transl Med. 2013 Nov 27;11:295. doi: 10.1186/1479-5876-11-295. PMID: 24279335